Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Dysadherin expression in gastrointestinal stromal tumors (GISTs)
Pathology - Research and Practice, 06/19/09
Liang JF et al. - The expression level of dysadherin is related to the risk of GISTs. Dysadherin upregulation, which may cause loss of E-cadherin, is one of the reasons for GISTs recurrence and metastasis. It seems that dysadherin protein detection is a promising method for GISTs prognostication.
Related Articles
Duodenal Gastrointestinal Stromal Tumor Treated by Wedge Resection in a Patient with Neurofibromatosis Type 1: Report of a Case and Review of the Japanese Literature
Case Reports in Gastroenterology, 11/23/09
Relevance Score: 82%%
Gastrointestinal stromal tumor causing small bowel intussusception in a patient with Crohn's disease
World Journal of Gastroenterology, 11/13/09
Relevance Score: 82%%
Multiple gastrointestinal stromal tumors in neurofibromatosis type 1: Report of a case
Surgery Today, 11/11/09
Relevance Score: 81%%
Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitro
Molecular Cancer, 11/23/09
Relevance Score: 80%%
Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy
Cancer Treatment Reviews, 11/19/09
Relevance Score: 80%%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Target genes suitable for silencing approaches and protein product interference in ovarian epithelial cancer
Cancer Treatment Reviews, 12/04/09
Dysregulation of Platelet-Derived Growth Factor beta-Receptor Expression by deltaNp73 in Neuroblastoma
Molecular Cancer Research, 12/04/09
Tissue transglutaminase 2 as a biomarker of cervical intraepithelial neoplasia (CIN) and its relationship to p16INK4A and nuclear factor kappaB expression
Virchows Archiv, 12/04/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer
Expert Review of Anticancer Therapy, 12/04/09
Clinical implications of esophagorespiratory fistulae in patients with esophageal squamous cell carcinoma (SCCA)
Medical Oncology, 12/04/09
Clinicopathological characteristics of primary gastric T-cell lymphoma
Histopathology, 12/04/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


